< -5%

-5% to -3%

Canara HSBC

PB Fintech

ICICI Lombard 

HDFC Life

SBI Life Insura

General Insuran

LIC India

-3% to 0%

Go Digit

ICICI Prudentia

Niva Bupa Healt

New India Assur

0% to 3%

3% to 5%

Royal Alpha Growth, Vorton Capital among 4 investors buy over 6% stake in Gabion Technologies, Arton Global picks up over 1% stake in Tarmat

* Royal Alpha Growth, Vorton Capital among 4 investors buy over 6% stake in Gabion Technologies
* Arton Global picks up over 1% stake in Tarmat

shorts/business/royal-alpha-growth-vorton-capital-among-4-investors-acquire-over-6-stake-in-gabion-technologies-on-its-market-debut

* Royal Alpha Growth, Vorton Capital among 4 investors buy over 6% stake in Gabion Technologies
* Arton Global picks up over 1% stake in Tarmat

Royal Alpha Growth, and Vorton Capital are among four investors who acquired over 6 percent equity stake in Gabion Technologies India, the steel wire mesh gabions maker, via open market transactions on its market debut i.e. January 13.

<a href="https://www.moneycontrol.com/india/stockpricequote/miscellaneous/gabiontechnologiesindialtd/GTI01">Gabion Technologies</a> shares rallied 5 percent on its first trading day, closing at Rs 93.41 on the BSE after hitting an intraday high of Rs 93.45 and low of Rs 84.55.

Among four investors, alternative investment fund Vorton Opportunities Fund, managed by asset management company Vorton Capital, was the largest buyer, acquiring additional 4.97 lakh shares (equivalent to 3.66 percent of paid-up equity) at Rs 89 per share for Rs 4.42 crore.

Vorton already held 1.01 percent stake (1.37 lakh shares) in Gabion Technologies that manufactures steel wire mesh gabions and provides services and technology in the fields of geo-systems, geotechnical engineering and ground improvement techniques. These shares were bought by Vorton through company's IPO anchor book on January 5.

The Gabion Technologies Rs 29-crore IPO attracted robust demand from investors, closing with more than 768 times subscription on January 8.

Further, Royal Alpha Growth-backed Royal Alpha Opportunity Fund has acquired 99,200 equity shares in Gabion at Rs 89 per share for Rs 88.28 lakh, and Kamal Kumar Dugar and Co also bought same number of shares at Rs 84.55 per share for Rs 83.87 lakh.

Nexus Equity Growth Fund SCH-1 picked up 1.48 lakh shares in Gabion at Rs 84.55 per share for Rs 1.25 crore.

Meanwhile, steel supplier Arton Global has bought 2.46 lakh shares (1.02 percent stake) in construction engineering company Tarmat at Rs 52.25 per share for Rs 1.28 crore.

<a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-civil/tarmat/RT06">Tarmat</a> shares saw significant buying interest on Tuesday, soaring 13.8 percent - the biggest single-day rally since July 2025, to close at Rs 54.03 amid high volumes on the NSE.

Ownership, Material Conflicts of Interest and Disciplinary History

MCD is a wholly owned subsidiary of Network 18 Media & Investments Ltd ("Network18"), in which Independent Media Trust (IMT) holds 56.89% stake. Reliance Industries Limited ("RIL") is the sole beneficiary of IMT. Network18 and RIL and their subsidiaries, joint ventures and associates can be considered as associates of MCD.

Details of Associate

Receipt of Compensation

Third-Party Compensation

Employment History

Market-Making Activities

Use of Artificial Intelligence

Royal Alpha Growth, Vorton Capital among 4 investors acquire over 6% stake in Gabion Technologies on its market debut

Royal Alpha Growth, and Vorton Capital are among four investors who acquired over 6 percent equity stake in Gabion Technologies India, the steel wire mesh gabions maker, via open market transactions on its market debut i.e. January 13.

Gabion Technologies shares rallied 5 percent on its first trading day, closing at Rs 93.41 on the BSE after hitting an intraday high of Rs 93.45 and low of Rs 84.55.

Among four investors, alternative investment fund Vorton Opportunities Fund, managed by asset management company Vorton Capital, was the largest buyer, acquiring additional 4.97 lakh shares (equivalent to 3.66 percent of paid-up equity) at Rs 89 per share for Rs 4.42 crore.

Vorton already held 1.01 percent stake (1.37 lakh shares) in Gabion Technologies that manufactures steel wire mesh gabions and provides services and technology in the fields of geo-systems, geotechnical engineering and ground improvement techniques. These shares were bought by Vorton through company's IPO anchor book on January 5.

The Gabion Technologies Rs 29-crore IPO attracted robust demand from investors, closing with more than 768 times subscription on January 8.

Further, Royal Alpha Growth-backed Royal Alpha Opportunity Fund has acquired 99,200 equity shares in Gabion at Rs 89 per share for Rs 88.28 lakh, and Kamal Kumar Dugar and Co also bought same number of shares at Rs 84.55 per share for Rs 83.87 lakh.

Nexus Equity Growth Fund SCH-1 picked up 1.48 lakh shares in Gabion at Rs 84.55 per share for Rs 1.25 crore.

Meanwhile, steel supplier Arton Global has bought 2.46 lakh shares (1.02 percent stake) in construction engineering company Tarmat at Rs 52.25 per share for Rs 1.28 crore.

Tarmat shares saw significant buying interest on Tuesday, soaring 13.8 percent - the biggest single-day rally since July 2025, to close at Rs 54.03 amid high volumes on the NSE.

Cipla shares drop 2% after US FDA approves rival's generic Advair inhaler., Aurobindo Pharma's Lannett acquisition may raise US revenue by $30-40 million, Cipla seeks FDA approval for generic Advair, may add $50M by FY27.

* Cipla shares drop 2% after US FDA approves rival's generic Advair inhaler.
* Aurobindo Pharma's Lannett acquisition may raise US revenue by $30-40 million
* Cipla seeks FDA approval for generic Advair, may add $50M by FY27.

Cipla shares fell nearly 2% after the US FDA approved rival Aurobindo Pharma's generic Advair inhaler, seen as a marginal negative for Cipla. Citi expects Cipla to get its own approval soon, with Advair potentially adding $50 million to US revenue by FY27.

shorts/business/cipla-shares-fall-up-to-2-as-citi-says-us-fda-nod-for-generic-advair-could-help-aurobindo-pharma

* Cipla shares drop 2% after US FDA approves rival's generic Advair inhaler.
* Aurobindo Pharma's Lannett acquisition may raise US revenue by $30-40 million
* Cipla seeks FDA approval for generic Advair, may add $50M by FY27.

The shares of <a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/cipla/C">Cipla</a> dropped nearly 2 percent to its day's high on January 13 after the US FDA granted its final approval to rival Aurobindo Pharma for a generic version of the GSK's Advair inhalers. Citi called the development a "marginal negative" for Cipla.

The shares of the pharma major dropped to a nine-month low of Rs 1,436.60 apiece, before recovering some losses to close at Rs 1,448 apiece.
<h3><strong>US FDA approves Lannett's generic Advair inhaler version:</strong></h3>
Respirent Pharmaceuticals and Lannett have received final approval from the US Food and Drug Administration (FDA) for a generic version of Advair Diskus, which is a key respiratory drug used to treat patients suffering from asthma and chronic obstructive pulmonary disease.

Notably, <a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/aurobindopharma/AP">Aurobindo Pharma</a> in July last year had announced the acquisition of Lannett for $250 million. Citi Research said that the generic version will likely add $30 million to $40 million to the company's annual US revenues.

Cipla has been awaiting FDA's approval for its own generic version of Advair. While noting that FDA's approval to Lannett was a "marginal negative" for Cipla, the international firm sees the pharma major getting the approval in near-term.

It further sees Advair contributing $50 million to Cipla's US revenue in FY27.
<h3><strong>Cipla share price:</strong></h3>
Cipla shares have fallen more than 3 percent in the past five days, and over 4 percent in the past one month. This comes after the stock gained around 76 percent in the past five years.

The stock currently has a P/E ratio of 21.70, and a market capitalization of nearly Rs 1.17 lakh crore.

Follow all <a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-firm-start-us-asian-markets-gain-liveblog-13769563.html">LIVE updates</a> from the stock markets here.

<em>(With inputs from agencies)</em>

<em>Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.</em>

Cipla shares fall up to 2% as Citi says US FDA nod for generic Advair could help Aurobindo Pharma

The shares of Cipla dropped nearly 2 percent to its day's high on January 13 after the US FDA granted its final approval to rival Aurobindo Pharma for a generic version of the GSK's Advair inhalers. Citi called the development a &quot;marginal negative&quot; for Cipla.

The shares of the pharma major dropped to a nine-month low of Rs 1,436.60 apiece, before recovering some losses to close at Rs 1,448 apiece.
US FDA approves Lannett's generic Advair inhaler version:
Respirent Pharmaceuticals and Lannett have received final approval from the US Food and Drug Administration (FDA) for a generic version of Advair Diskus, which is a key respiratory drug used to treat patients suffering from asthma and chronic obstructive pulmonary disease.

Notably, Aurobindo Pharma in July last year had announced the acquisition of Lannett for $250 million. Citi Research said that the generic version will likely add $30 million to $40 million to the company's annual US revenues.

Cipla has been awaiting FDA's approval for its own generic version of Advair. While noting that FDA's approval to Lannett was a &quot;marginal negative&quot; for Cipla, the international firm sees the pharma major getting the approval in near-term.

It further sees Advair contributing $50 million to Cipla's US revenue in FY27.
Cipla share price:
Cipla shares have fallen more than 3 percent in the past five days, and over 4 percent in the past one month. This comes after the stock gained around 76 percent in the past five years.

The stock currently has a P/E ratio of 21.70, and a market capitalization of nearly Rs 1.17 lakh crore.

Follow all LIVE updates from the stock markets here.

(With inputs from agencies)

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

RedTape shares surged nearly 16 percent after founders explored stake sale, Promoters appointed EY to advise on divestment, approached Blackstone and KKR, RedTape may sell majority or entire stake valued at around USD 510 million

* RedTape shares surged nearly 16 percent after founders explored stake sale
* Promoters appointed EY to advise on divestment, approached Blackstone and KKR
* RedTape may sell majority or entire stake valued at around USD 510 million

RedTape shares surged nearly 16% after reports that its founders are considering selling their stake, reaching out to private equity firms like Blackstone and KKR. The Mirza family has appointed EY as adviser for the potential $510 million divestment.

shorts/business/footwear-firm-redtape-shares-rise-5-as-report-says-founders-eye-stake-sale-tap-blackstone-kkr

* RedTape shares surged nearly 16 percent after founders explored stake sale
* Promoters appointed EY to advise on divestment, approached Blackstone and KKR
* RedTape may sell majority or entire stake valued at around USD 510 million

Shares of footwear maker RedTape on Monday surged nearly 16 percent after a report said the company’s founders are exploring a sale of their stake and have reached out to private equity firms.

On the NSE, <a href="https://www.moneycontrol.com/india/stockpricequote/footwear/redtape/R04">RedTape</a> stock climbed 15.95 percent to an intraday high of Rs 134.80 a share. The gain came after the stock had fallen for three straight sessions. The stock settled at Rs 128.26 per share, up 10.33 percent.

The rise followed a Reuters report that RedTape is seeking proposals from private equity firms Blackstone and KKR, as its founding family looks to sell a majority stake or even its entire holding valued at around USD 510 million.

The report said RedTape’s promoters, the Mirza family, have appointed consultancy firm Ernst &amp; Young as the exclusive financial adviser for the divestment of their stake, according to a document dated December that was seen by Reuters.

EY has approached firms such as Blackstone and KKR &amp; Co to gauge interest in a possible transaction, the report said, citing people familiar with the matter.

Launched in 1996, RedTape operates in the footwear and apparel segment and competes with players such as Nike, Adidas, Bata India and Campus Activewear.

The footwear and apparel market is projected to grow at about 11 percent annually to USD 21 billion by 2028, according to estimates by market research firm 1Lattice.

<em><strong>Disclaimer</strong>: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.</em>

Footwear firm RedTape shares settle 10% higher as report says founders eye stake sale, tap Blackstone, KKR

Shares of footwear maker RedTape on Monday surged nearly 16 percent after a report said the company’s founders are exploring a sale of their stake and have reached out to private equity firms.

On the NSE, RedTape stock climbed 15.95 percent to an intraday high of Rs 134.80 a share. The gain came after the stock had fallen for three straight sessions. The stock settled at Rs 128.26 per share, up 10.33 percent.

The rise followed a Reuters report that RedTape is seeking proposals from private equity firms Blackstone and KKR, as its founding family looks to sell a majority stake or even its entire holding valued at around USD 510 million.

The report said RedTape’s promoters, the Mirza family, have appointed consultancy firm Ernst &amp;amp; Young as the exclusive financial adviser for the divestment of their stake, according to a document dated December that was seen by Reuters.

EY has approached firms such as Blackstone and KKR &amp;amp; Co to gauge interest in a possible transaction, the report said, citing people familiar with the matter.

Launched in 1996, RedTape operates in the footwear and apparel segment and competes with players such as Nike, Adidas, Bata India and Campus Activewear.

The footwear and apparel market is projected to grow at about 11 percent annually to USD 21 billion by 2028, according to estimates by market research firm 1Lattice.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Swiggy, Eternal shares drop amid 10-minute delivery branding discussions., Major delivery platforms agreed to stop marketing 10-minute delivery services, Move aims to improve safety and working conditions for gig workers

* Swiggy, Eternal shares drop amid 10-minute delivery branding discussions.
* Major delivery platforms agreed to stop marketing 10-minute delivery services
* Move aims to improve safety and working conditions for gig workers

Swiggy and Eternal shares fell from intraday highs after reports that the government urged delivery firms to stop 10-minute delivery branding for worker safety. Major platforms agreed to comply, following protests over wages and working conditions.

shorts/business/swiggy-eternal-shares-off-day-s-highs-as-reports-say-blinkit-removes-10-minute-delivery-deadline

* Swiggy, Eternal shares drop amid 10-minute delivery branding discussions.
* Major delivery platforms agreed to stop marketing 10-minute delivery services
* Move aims to improve safety and working conditions for gig workers

Eternal-owned quick-commerce firm Blinkit has dropped its '10-minute' delivery claim from all platforms amid growing concerns over delivery workers' welfare.

It has revised the tag-line from "10,000+ products delivered in 10 minutes" to "30,000+ products delivered at your doorstep".

This comes after Union Labour Minister Mansukh Mandaviya held meetings over the past month with major quick commerce and delivery platforms, including Blinkit, Zepto, Zomato and Swiggy, to discontinue the marketing and branding of 10-minute delivery services.

Other quick commerce platforms, such as Swiggy and Zepto, may also follow suit after the intervention by the Union Ministry of Labour, which was concerned about the welfare of the delivery workers trying to meet such tight deadlines.

The promise of 10-minute delivery led to gig workers holding a nationwide strike on New Year's Eve in 2025, drawing attention to workers' health, safety and income.

Shares of <a href="https://www.moneycontrol.com/india/stockpricequote/online-services/swiggy/SL24">Swiggy</a> settled marginally higher at Rs 350.2 per share, up 0.17 percent. The stock trimmed some of its gains after Blinkit's annoucement.

Shares of <a href="https://www.moneycontrol.com/india/stockpricequote/online-services/eternal/Z">Eternal</a> settled near day's high at Rs 294.25 per share, up 3.16 percent.

The move is aimed at ensuring greater safety, security and improved working conditions for gig workers. Other quick commerce aggregators are expected to follow suit in the coming days.
<h3><em>(With inputs from PTI)</em></h3>
<em><strong>Disclaimer:</strong> The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.</em>

A financial journalist with over 10 years of experience, specialising in tracking stock market movements and fundamental developments that impact investors and the broader economy. A keen observer of global financial markets, I regularly engage with leading market voices to write stories. At Moneycontrol, I focus on decoding market trends, policy shifts and economic changes, driven by a constant passion to learn, analyse, and share knowledge with my readers.

Blinkit drops 10-minute delivery deadline; here's how Swiggy, Eternal shares reacted

Eternal-owned quick-commerce firm Blinkit has dropped its '10-minute' delivery claim from all platforms amid growing concerns over delivery workers' welfare.

It has revised the tag-line from &quot;10,000+ products delivered in 10 minutes&quot; to &quot;30,000+ products delivered at your doorstep&quot;.

This comes after Union Labour Minister Mansukh Mandaviya held meetings over the past month with major quick commerce and delivery platforms, including Blinkit, Zepto, Zomato and Swiggy, to discontinue the marketing and branding of 10-minute delivery services.

Other quick commerce platforms, such as Swiggy and Zepto, may also follow suit after the intervention by the Union Ministry of Labour, which was concerned about the welfare of the delivery workers trying to meet such tight deadlines.

The promise of 10-minute delivery led to gig workers holding a nationwide strike on New Year's Eve in 2025, drawing attention to workers' health, safety and income.

Shares of Swiggy settled marginally higher at Rs 350.2 per share, up 0.17 percent. The stock trimmed some of its gains after Blinkit's annoucement.

Shares of Eternal settled near day's high at Rs 294.25 per share, up 3.16 percent.

The move is aimed at ensuring greater safety, security and improved working conditions for gig workers. Other quick commerce aggregators are expected to follow suit in the coming days.
(With inputs from PTI)
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Ixigo shares jumped over 9 percent after JM Financial upgraded rating to 'Buy', JM Financial sees temporary slowdown but expects long-term growth for Ixigo, Target price cut to Rs 275, implying over 29 percent upside from previous close

* Ixigo shares jumped over 9 percent after JM Financial upgraded rating to 'Buy'
* JM Financial sees temporary slowdown but expects long-term growth for Ixigo
* Target price cut to Rs 275, implying over 29 percent upside from previous close

Ixigo-parent Le Travenues Technology shares rose over 9% after JM Financial upgraded the stock to ‘Buy’ from ‘Reduce’, citing improved risk-reward and long-term growth prospects, despite lowering the target price to Rs 275 due to earnings cuts.

shorts/business/ixigo-shares-jump-9-on-jm-financial-s-double-upgrade-says-correction-is-overdone

* Ixigo shares jumped over 9 percent after JM Financial upgraded rating to 'Buy'
* JM Financial sees temporary slowdown but expects long-term growth for Ixigo
* Target price cut to Rs 275, implying over 29 percent upside from previous close

The shares of <a href="https://www.moneycontrol.com/india/stockpricequote/travel-services/letravenuestechnologyixigo/LTT">Ixigo</a>-parent Le Travenues Technology jumped more than 9 percent on January 13 after JM Financial upgraded its rating on the stock to 'Buy' from 'Reduce', citing multiples reasons.

The shares of the company rose to Rs 232.55 apiece, snapping a four-session losing streak.
<h3><strong>JM Financial on Ixigo:</strong></h3>
JM Financial noted that Ixigo shares have corrected approximately 20 percent since the end of November 2025 due to expectation of relatively slower growth in the flights business in Q3 and Q4 FY26 after recent disruptions in the industry and an unfavourable base (Kumbh Mela benefit last year), and uncertainty around margin due to ramp-up in its tech, supply-side and promotional investments towards hotels’ OTA.

However, the domestic brokerage believes that the current phase represents a temporary earnings and sentiment overhang, which shall ease over the next few quarters. “From a medium-to-long-term perspective, Ixigo remains well positioned to grow faster than peers owing to its effective cross-sell of services across various apps, sharp focus on superior customer experience and robust traction for its differentiated value-added services,” it added.

JM Financial however lowered its target price for the stock to Rs 275 per share from Rs 300 per share, based on a cut in FY26–28E earnings by 4–8 percent and target P/E to 60x (from 65x). The latest target price implies an upside potential of more than 29 percent from the stock’s previous closing price.

The domestic brokerage noted that the recent correction has materially improved the risk-reward, prompting the double upgrade.
<h3><strong>Ixigo share price:</strong></h3>
Ixigo shares have fallen more than 3 percent in the past five days, and over 8 percent in the past one month. This came after the stock jumped 29.5 percent in the past six months, and around 61 percent in the past one year.

The stock currently has a P/E ratio of 164.28. Its market capitalization stands at Rs 10,016 crore.

Follow all <a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-updates-gift-nifty-indicates-a-firm-start-us-asian-markets-gain-liveblog-13769563.html">LIVE updates</a> from the stock markets here.

<em>Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.</em>

Ixigo shares jump 9% on JM Financial's double upgrade, says correction is 'overdone'

The shares of Ixigo-parent Le Travenues Technology jumped more than 9 percent on January 13 after JM Financial upgraded its rating on the stock to 'Buy' from 'Reduce', citing multiples reasons.

The shares of the company rose to Rs 232.55 apiece, snapping a four-session losing streak.
JM Financial on Ixigo:
JM Financial noted that Ixigo shares have corrected approximately 20 percent since the end of November 2025 due to expectation of relatively slower growth in the flights business in Q3 and Q4 FY26 after recent disruptions in the industry and an unfavourable base (Kumbh Mela benefit last year), and uncertainty around margin due to ramp-up in its tech, supply-side and promotional investments towards hotels’ OTA.

However, the domestic brokerage believes that the current phase represents a temporary earnings and sentiment overhang, which shall ease over the next few quarters. “From a medium-to-long-term perspective, Ixigo remains well positioned to grow faster than peers owing to its effective cross-sell of services across various apps, sharp focus on superior customer experience and robust traction for its differentiated value-added services,” it added.

JM Financial however lowered its target price for the stock to Rs 275 per share from Rs 300 per share, based on a cut in FY26–28E earnings by 4–8 percent and target P/E to 60x (from 65x). The latest target price implies an upside potential of more than 29 percent from the stock’s previous closing price.

The domestic brokerage noted that the recent correction has materially improved the risk-reward, prompting the double upgrade.
Ixigo share price:
Ixigo shares have fallen more than 3 percent in the past five days, and over 8 percent in the past one month. This came after the stock jumped 29.5 percent in the past six months, and around 61 percent in the past one year.

The stock currently has a P/E ratio of 164.28. Its market capitalization stands at Rs 10,016 crore.

Follow all LIVE updates from the stock markets here.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Insurance Sector Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Insurance sector stocks.

Gainers/Losers

Sector Market Map

Earnings Review-Q3 FY25-26

Stock News

Royal Alpha Growth, Vorton Capital among 4 investors acquire over 6% stake in Gabion Technologies on its market debut

Cipla shares fall up to 2% as Citi says US FDA nod for generic Advair could help Aurobindo Pharma

Footwear firm RedTape shares settle 10% higher as report says founders eye stake sale, tap Blackstone, KKR

Blinkit drops 10-minute delivery deadline; here's how Swiggy, Eternal shares reacted

Ixigo shares jump 9% on JM Financial's double upgrade, says correction is 'overdone'

Insurance Sector StocksCheck latest stock performance, list of stocks, earnings review & more details about the Insurance sector stocks.

Gainers/Losers

Sector Market Map

Earnings Review-Q3 FY25-26

Stock News

Royal Alpha Growth, Vorton Capital among 4 investors acquire over 6% stake in Gabion Technologies on its market debut

Cipla shares fall up to 2% as Citi says US FDA nod for generic Advair could help Aurobindo Pharma

Footwear firm RedTape shares settle 10% higher as report says founders eye stake sale, tap Blackstone, KKR

Blinkit drops 10-minute delivery deadline; here's how Swiggy, Eternal shares reacted

Ixigo shares jump 9% on JM Financial's double upgrade, says correction is 'overdone'

Insurance Sector Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Insurance sector stocks.